Page last updated: 2024-08-24

ibandronic acid and Invasiveness, Neoplasm

ibandronic acid has been researched along with Invasiveness, Neoplasm in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ehrenfeld, M; Mayr, D; Oduncu, F; Otto, S; Pautke, C; Troeltzsch, M1
Bielawski, KP; Bosse, U; Schlotter, CM; Vogt, U1
Allhoff, EP; Lindenmeir, T; Rau, O; Reiher, F; Ulrich, M1
Bauss, F; De Clerck, YA; Dunstan, C; Mundy, GR; Sasaki, A; Williams, PJ; Yoneda, T1
Boissier, S; Clezardin, P; Delmas, PD; Magnetto, S1
Boissier, S; Clézardin, P; Colombel, M; Delaissé, JM; Delmas, P; Ebetino, FH; Ferreras, M; Magnetto, S; Peyruchaud, O1

Reviews

1 review(s) available for ibandronic acid and Invasiveness, Neoplasm

ArticleYear
Root resorption caused by jaw infiltration of multiple myeloma: report of a case and literature review.
    Journal of endodontics, 2014, Volume: 40, Issue:8

    Topics: Aged; Antineoplastic Agents; Bicuspid; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Humans; Ibandronic Acid; Male; Mandibular Neoplasms; Molar; Multiple Myeloma; Neoplasm Invasiveness; Osteolysis; Root Resorption; Stem Cell Transplantation; Tooth Mobility

2014

Other Studies

5 other study(ies) available for ibandronic acid and Invasiveness, Neoplasm

ArticleYear
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
    Oncology reports, 2004, Volume: 12, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; Diphosphonates; Docetaxel; Drug Synergism; Epirubicin; Female; Fluorouracil; Humans; Ibandronic Acid; Imidazoles; In Vitro Techniques; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasms, Ductal, Lobular, and Medullary; Paclitaxel; Taxoids; Zoledronic Acid

2004
[Adjuvant therapy of locally advanced prostate carcinoma with ibandronate].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:9

    Topics: Biomarkers, Tumor; Bone Density Conservation Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Diphosphonates; Drug Administration Schedule; Humans; Ibandronic Acid; Infusions, Intravenous; Long-Term Care; Male; Neoplasm Invasiveness; Neoplasm Staging; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms

2007
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    The Journal of clinical investigation, 1997, May-15, Volume: 99, Issue:10

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Survival; Diphosphonates; Female; Genetic Therapy; Heart Ventricles; Humans; Ibandronic Acid; Mice; Mice, Nude; Neoplasm Invasiveness; Osteolysis; Protein Biosynthesis; Tibia; Tissue Inhibitor of Metalloproteinase-2; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured

1997
Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone.
    International journal of cancer, 1999, Oct-08, Volume: 83, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Diphosphonates; Docetaxel; Drug Synergism; Humans; Ibandronic Acid; Neoplasm Invasiveness; Paclitaxel; Taxoids; Tumor Cells, Cultured

1999
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
    Cancer research, 2000, Jun-01, Volume: 60, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Movement; Clodronic Acid; Collagen; Diphosphonates; Dose-Response Relationship, Drug; Drug Combinations; Flow Cytometry; Fluorometry; Humans; Ibandronic Acid; Imidazoles; Laminin; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Prostatic Neoplasms; Proteoglycans; Pyridines; Pyridinium Compounds; Tumor Cells, Cultured; Zinc; Zoledronic Acid

2000